Company performance
Add to research
Current Price
as of Jun 13, 2025$2.46
P/E Ratio
N/A
Market Cap
$107.45M
Description
Add to research
Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.
Metrics
Add to research
Overview
- HQSan Diego, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerKTRA
- Price$2.46-6.11%
Trading Information
- Market cap$107.45M
- Float56.50%
- Average Daily Volume (1m)134,089
- Average Daily Volume (3m)191,066
- EPS-$1.21
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$6.66M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$7.00M
- EV$134.42M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B11.22
- Debt/Equity1.67
Documents
Add to research
SEC Filings